Tralokinumab for moderate-to-severe UC: a randomised,...

Gut 2015 / 02 Vol. 64; Iss. 2

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Danese, S., Rudzinski, J., Brandt, W., Dupas, J.-L., Peyrin-Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukas, M., Knutsson, M., Erlandsson, F., Hansen, M. B., Keshav, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
64
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2014-308004
Date:
February, 2015
File:
PDF, 653 KB
english, 2015
Conversion to is in progress
Conversion to is failed